These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 29127353

  • 1. Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma.
    Liu Y, Wu H, Mei Y, Ding X, Yang X, Li C, Deng M, Gong J.
    Sci Rep; 2017 Nov 10; 7(1):15294. PubMed ID: 29127353
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of Pyruvate Kinase M2 in Tumor Tissues Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
    Zhao R, Li L, Yang J, Niu Q, Wang H, Qin X, Zhu N, Shi A.
    Pathol Oncol Res; 2020 Apr 10; 26(2):853-860. PubMed ID: 30852741
    [Abstract] [Full Text] [Related]

  • 3. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W, Lu SX, Li M, Zhang C, Liu LL, Fu J, Jin JT, Luo RZ, Zhang CZ, Yun JP.
    Oncotarget; 2015 Mar 30; 6(9):6570-83. PubMed ID: 25788265
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL, Song JJ, Chen XC, Xu W, Zhi Q, Liu YP, Xu HZ, Pan JS, Ren JL, Guleng B.
    World J Gastroenterol; 2015 Aug 14; 21(30):9093-102. PubMed ID: 26290635
    [Abstract] [Full Text] [Related]

  • 5. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q, Tu J, Dou C, Zhang J, Yang L, Liu X, Lei K, Liu Z, Wang Y, Li L, Bao H, Wang J, Tu K.
    Mol Cancer; 2017 Dec 20; 16(1):178. PubMed ID: 29262861
    [Abstract] [Full Text] [Related]

  • 6. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR, Tian MX, Yang LX, Lin YL, Jin L, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, He R, Fan J, Shi YH.
    Oncotarget; 2015 Jan 20; 6(2):846-61. PubMed ID: 25514599
    [Abstract] [Full Text] [Related]

  • 7. Nuclear PKM2 expression, an independent risk factor for ER after curative resection of hepatocellular carcinoma.
    Fan F, Wu H, Liu Z, Hou X, Chen W, Wang A, Lu Y.
    Biomed Pharmacother; 2016 Dec 20; 84():1858-1864. PubMed ID: 27894667
    [Abstract] [Full Text] [Related]

  • 8. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B, Shah V, Onyshchenko M, Elshamy M, Aucejo F, Lopez R, Hanouneh IA, Alhaddad R, Alkhouri N.
    Hepatol Int; 2016 Jul 20; 10(4):632-9. PubMed ID: 26558795
    [Abstract] [Full Text] [Related]

  • 9. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
    Chen Z, Lu X, Wang Z, Jin G, Wang Q, Chen D, Chen T, Li J, Fan J, Cong W, Gao Q, He X.
    Oncotarget; 2015 Feb 10; 6(4):2538-48. PubMed ID: 25576919
    [Abstract] [Full Text] [Related]

  • 10. COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway.
    Wang Q, Lu D, Fan L, Li Y, Liu Y, Yu H, Wang H, Liu J, Sun G.
    Int J Mol Med; 2019 Jan 10; 43(1):475-488. PubMed ID: 30365092
    [Abstract] [Full Text] [Related]

  • 11. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
    Ma HX, Shu QH, Pan JJ, Liu D, Xu GL, Li JS, Ma JL, Jia WD, Yv JH, Ge YS.
    Tumour Biol; 2015 Jun 10; 36(6):4235-41. PubMed ID: 25592379
    [Abstract] [Full Text] [Related]

  • 12. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
    Wong CC, Au SL, Tse AP, Xu IM, Lai RK, Chiu DK, Wei LL, Fan DN, Tsang FH, Lo RC, Wong CM, Ng IO.
    PLoS One; 2014 Jun 10; 9(12):e115036. PubMed ID: 25541689
    [Abstract] [Full Text] [Related]

  • 13. Effects of PKM2 on global metabolic changes and prognosis in hepatocellular carcinoma: from gene expression to drug discovery.
    Lv WW, Liu D, Liu XC, Feng TN, Li L, Qian BY, Li WX.
    BMC Cancer; 2018 Nov 21; 18(1):1150. PubMed ID: 30463528
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D, Chen Y, Yan Y, Pan J, Xing W, Li Q, Zeng W.
    BMC Cancer; 2017 Aug 18; 17(1):553. PubMed ID: 28821282
    [Abstract] [Full Text] [Related]

  • 15. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Wubetu GY, Morine Y, Teraoku H, Yoshikawa M, Ishikawa D, Yamada S, Ikemoto T, Saito YU, Imura S, Shimada M.
    Anticancer Res; 2016 Feb 18; 36(2):757-62. PubMed ID: 26851035
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues.
    Deli G, Jin CH, Mu R, Yang S, Liang Y, Chen D, Makuuchi M.
    World J Gastroenterol; 2005 Feb 21; 11(7):960-3. PubMed ID: 15742396
    [Abstract] [Full Text] [Related]

  • 17. Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis.
    Kim JM, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
    Ann Surg Oncol; 2014 Feb 21; 21(2):458-65. PubMed ID: 24132624
    [Abstract] [Full Text] [Related]

  • 18. PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment.
    Li TE, Wang S, Shen XT, Zhang Z, Chen M, Wang H, Zhu Y, Xu D, Hu BY, Wei R, Zheng Y, Dong QZ, Qin LX.
    Front Immunol; 2020 Feb 21; 11():589997. PubMed ID: 33193421
    [Abstract] [Full Text] [Related]

  • 19. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma.
    Dayton TL, Gocheva V, Miller KM, Israelsen WJ, Bhutkar A, Clish CB, Davidson SM, Luengo A, Bronson RT, Jacks T, Vander Heiden MG.
    Genes Dev; 2016 May 01; 30(9):1020-33. PubMed ID: 27125672
    [Abstract] [Full Text] [Related]

  • 20. [Influence of cirrhosis on long-term outcomes after liver resection in patients with a single small hepatocellular carcinoma].
    Liang BY, Huang ZY, Liu YA, Hou P, Ji GB, Chen XP.
    Zhonghua Wai Ke Za Zhi; 2012 Oct 01; 50(10):865-9. PubMed ID: 23302452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.